Bebangco, Elliesha Kate A.
HRN: 10-44-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFUROXIME 750MG (VIAL)
10/17/2022
10/24/2022
IVTT
525mg
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes